Youtube
BETA

Beta Drugs Ltd.

₹843.2

Score

65

Technically Moderately Bullish

Beta Drugs Price Change Analysis

Beta Drugs Key Statistics
  • P/E Ratio

    58.6

  • PEG Ratio

  • Market Cap Cr

    810.6

  • Price to Book Ratio

    80.6

  • EPS

    14.8

  • Dividend

    0 ()

  • Relative Strength Index

    62.33

  • Money Flow Index

    70.56

  • MACD Signal

    66.2

  • Average True Range

    60.7

Investment Ratings

  • Master Rating:

EPS Strength

Price Strength

Buyer Demand

Group Rank

Result Highlights

Beta Drugs Synopsis

NSE-Medical-Diversified

Beta Drugs is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 124.85 Cr. and Equity Capital is Rs. 9.61 Cr. for the Year ended 31/03/2022. Beta Drugs Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24230HP2005PLC028969 and registration number is 028969.
  • Market Cap

    825.84

  • Sales

    124.85

  • Shares in Float

    0.32

  • No of Funds

    1

  • Yield

  • Book Value

    10.79

  • U/D Vol Ratio

    1.5

  • LTDebt/Equity

    7

  • Alpha

    0.52

  • Beta

    0.86

Beta Drugs Ownership
Beta Drugs Management

Beta Drugs Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Eps And Sales Estimates

Beta Drugs Financials

Beta Drugs Technicals

EMA & SMA

CURRENT PRICE

EMA

Beta Drugs Resistance and Support

Beta Drugs Delivery and Volume

Beta Drugs Price Change Analysis

Corporate Action

MF Shareholding

Similar Stocks

Videos

About Company

News

FAQs

Beta Drugs share price is

Open Demat Account